Cutler Group LP Seres Therapeutics, Inc. Transaction History

Cutler Group LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$2.33 - $5.07 $186 - $405	-80 Reduced 1.27%	6,220 $14,000
Q2 2023 Jul 18, 2023	BUY	$4.67 - $6.55 $11,675 - $16,375	2,500 Added 65.79%	6,300 $30,000
Q1 2023 May 01, 2023	SELL	$4.95 - $6.09 $495 - $609	-100 Reduced 2.56%	3,800 $21,000
Q1 2022 Apr 14, 2022	SELL	$6.3 - $8.84 $14,490 - $20,332	-2,300 Reduced 37.1%	3,900 $27,000
Q4 2021 Jan 18, 2022	SELL	$6.02 - $11.43 $10,601 - $20,128	-1,761 Reduced 22.12%	6,200 $51,000
Q3 2021 Oct 26, 2021	BUY	$5.46 - $22.6 $25,995 - $107,598	4,761 Added 148.78%	7,961 $55,000
Q2 2021 Jul 19, 2021	BUY	$18.46 - $24.36 $42,458 - $56,028	2,300 Added 255.56%	3,200 $76,000
Q4 2020 Jan 21, 2021	SELL	$23.25 - $37.73 $132,222 - $214,570	-5,687 Reduced 86.34%	900 $22,000
Q3 2020 Oct 27, 2020	SELL	$3.74 - $28.74 $15,008 - $115,333	-4,013 Reduced 37.86%	6,587 $186,000
Q1 2019 May 10, 2019	BUY	$4.83 - $7.21 $1,043 - $1,557	216 Added 2.08%	10,600 $72,000
Q2 2018 Aug 10, 2018	SELL	$6.91 - $9.55 $6,910 - $9,550	-1,000 Reduced 8.78%	10,384 $89,000
Q4 2017 Jan 17, 2018	BUY	$9.15 - $12.64 $8,235 - $11,376	900 Added 8.58%	11,384 $115,000
Q3 2017 Oct 17, 2017	BUY	$12.81 - $16.85 $134,300 - $176,655	10,484	10,484 $168,000

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.